IFIH1 and dermatomyositis: (iv) Anti-MDA5 antibody-positive patients consistently exhibited higher LDH and ferritin levels, lower lymphocyte levels, higher probability of RP-ILD and ILD occurrence, and worse prognosis than anti-MDA5 antibody-negative patients, irrespective of DM, CADM, or CDM.